Advancing Beyond Barriers: Improved Eligibility and Outcomes in Allogeneic HCT Lunch and Learn

This one-hour Lunch and Learn will present an overview of key advances in hematopoietic cell transplant (HCT) outcomes and eligibility, highlighting relevant clinical research and updated guidance for the referring hematology-oncology team and fellows.